ESG Trends in Pharmaceutical Industry

Report Code: ENV061A

Publish Date: Feb 2023

Publisher: BCC Publishing

Category: Environment

Download Report Overview

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

This report provides a review of ESG trends in the pharmaceutical market, focusing on current trends and developments. The report will have a detailed analysis of key opportunities that would help in the market growth. It will also analyze the major challenges faced by pharmaceutical manufacturers and industry players.

Report Includes

  • A brief general outlook of the ESG trends in pharmaceutical industry
  • Detailed information about ESG-related developments in the pharmaceutical industry and analyses of factors affecting ESG applications
  • Discussion of current trends and issues in the pharmaceutical industry, with emphasis on major challenges and opportunities
  • Analysis of the whole supply chain of the pharmaceutical industry and its association with ESG
  • Information on major causes, and impact of pharmaceutical pollution and a detailed case study related to pharmaceutical pollution

Report Scope

The report will provide an outline of the global pharmaceutical industry and an ESG overview of the pharmaceutical industry. Qualitative insights on ESG trends and their impact on pharmaceutical manufacturers are provided, along with a detailed analysis of the pharmaceutical industry supply chain with regard to ESG. The report explains the primary drivers, challenges and trends influencing ESG implementation in the pharmaceutical industry.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

Environmental, social, and governance (ESG) investing is a set of standards for a company's conduct used to assess possible investments by socially concerned investors.
Increasing environmental regulations are driving the growth of ESG in the pharmaceutical Industry.
ESG is crucial for several reasons, including reacting to investor demand and controlling financial risks, as well as lowering costs and waste and boosting public relations.
ESG initiatives that are effective may save corporate expenditures in a variety of ways. Sustainable methods, for example, might considerably cut energy and water use, as well as the cost of packing and the quantity of waste your organization generates.
Companies that execute successful ESG strategies, for example, may be less vulnerable to supply chain interruptions and other ESG concerns. They may also discover that they are more ready to act when ESG problems arise.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: ESG Trends in Pharmaceutical Industry36Free

Related Reports

ESG Trends in the Healthcare Industry

Published - Mar 2023 | Publisher - BCC Publishing | Code - ENV064A

This report provides an analysis of environmental, social and governance (ESG) trends in the healthcare industry, with emphasis on current trends and future strategic developments. It includes healthcare equipment and services providers, biotechnology companies, and life sciences tools and services companies. The report provides ESG-related case studies and a general industry overview. The report focuses on the changing trends, market restraints, drivers and opportunities likely to drive ESG investment in the healthcare industry.

ESG in the Automobile Industry

Published - Jan 2023 | Publisher - BCC Publishing | Code - ENV057A

The three pillars of environmental, social and governance (ESG) define the standards and practices that, taken as a whole, reveal an organization's commitment to operating sustainably. The goal is to provide an up-to-date analysis of the ESG market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the ESG. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Regulatory Intelligence Report for Pharmaceuticals in the U.S.

Published - Nov 2022 | Publisher - BCC Publishing | Code - PHM267A

This report presents an understanding of the regulations and requirements of companies in the U.S., as well as foreign companies or establishments planning to manufacture, distribute or market their pharmaceuticals in the U.S. This report provides a brief about the related regulations for registration of the establishments and pharmaceuticals.

Recent Reports

Green Hydrogen: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - ENV060B

The global market for green hydrogen is expected to grow from $5.2 billion in 2024 and is projected to reach $38.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 48.7% during the forecast period of 2024 to 2029.

Water Meters, Water Quality Sensors and Water Leak Detection: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - ENV039C

The global market for water meters is estimated to increase from $15.0 billion in 2023 to reach $19.3 billion by 2029, at a compound annual growth rate (CAGR) of 4.5% from 2024 through 2029.

Circular Economy: A Global Outlook

Published - Aug 2024 | Publisher - BCC Publishing | Code - ENV073A

This report provides an in-thorough analysis of the circular economy market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, and opportunities, along with market projections for 2029 and rankings of key market players.

Green Mining: Global Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - ENV067A

The global market for green mining is estimated to increase from $11.4 billion in 2023 to reach $16.9 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Green Tires Market

Published - Jul 2024 | Publisher - Noopur Deshmukh | Code - ENV072A

The global market for green tires is expected to grow from $88.2 billion in 2024 and is projected to reach $152.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
ESG Trends in Pharmaceutical Industry
Customize Report Sample Report